COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain-Reference-Cited by-同舟云学术

COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain

Author:

Queiro Silva Rubén¹,Armesto Susana²^ORCID,González Vela Carmen³,Naharro Fernández Cristina²,González‐Gay Miguel Angel⁴

Affiliation:

1. Rheumatology Division Hospital Universitario Central de Asturias Oviedo Spain

2. Department of Dermatology Hospital Universitario Marqués de Valdecilla Santander Spain

3. Department of Pathology Hospital Universitario Marqués de Valdecilla Santander Spain

4. Department of Rheumatology Hospital Universitario Marqués de Valdecilla Santander Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

Reference17 articles.

4. COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action;Conforti C;Dermatol Ther,2020

5. Comment on "COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action";Abdelmaksoud A;Dermatol Ther,2020

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献